Comparison of Kinesio Taping and Local Injection in Chronic Low Back Pain

Low back pain can be seen in every period of life. More than 80 percent of the society complain of low back pain at any time of life. Although the frequency of applying to a health institution due to low back pain varies from one society to the other, it takes place in the first three places in each community. Low back pain should be differentiated as new (acute) and long-term (chronic). In the treatment of chronic low back pain, rest, education, pharmacological treatment, physical therapy, painful point injections, surgical interventions, kinesio taping can be applied. The most frequently used physical therapy modalities for treatment of chronic low back pain are superficial and deep heat modalities (hot pack, infrared, ultrasound, microwave diathermy radar) and analgesic effective electrotherapy (TENS, interferential flows) modalities. One of the most important treatments is exercise therapy. In cases where conventional treatment of chronic low back pain is insufficient, that is, the patient's pain is still ongoing and functional recovery is insufficient, some alternative methods are also applied. These treatments include ozone, prolotherapy injection applications, dry needling, acupuncture, phytotherapy, balneotherapy, kinesio taping and so on. The aim of this study is to compare the efficacy of painful point injection and kinesio taping treatments in lumbar region in patients with chronic low back pain.

Study Overview

• Status: Completed
• Conditions: Chronic Low Back Pain
• Intervention / Treatment: Other: kinesio tape; Other: local anesthetic; Other: local serum physiologic

Detailed Description

Approximately 84 volunteer patients will be included in the study, patients older than 18 years, under 75 years of age, with a minimum of 3 months of mechanical back pain, Visual Analog Scale score of at least 60 patients will be included. Who are older than 18 years of age, having mental problems, having peripheral problems affecting the central nervous system, having received physical therapy to the lumbar region in the last 3 months, having been applied to the lumbar region within the last 3 months, having a history of lumbar region surgery, having a history of patients with motor deficit in the extremity, needle phobia, lidocaine and / or kinesio tape allergy, patients with wound, infection, burn, allergic lesions in the application area will not be included.

Patients included in the study will be included in the first (first), second (second), third (third) or fourth (fourth) treatment group by random number generator method.

The first group will be given the hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days.

The second group will be given a hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16 days.

The third group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days, kinesio tape will be applied to the determined areas.

the fourth group hot package (20 minutes / day) + exercise + 1. 4. 7. 10. 13. 16. days sham tape application will be made in the regions determined. ****

• Patients in all groups will continue to use the hotpack and exercises until the 3rd month after the first day of their study. First session exercises with the same physiotherapist (stretching for back-waist, iliopsoas and hamstring muscles; exercise range of hip and waist; hip and waist isometric exercises). Each patient will do the exercises 20 minutes after the hot package application.

  • saline and local anesthetic injection points to be applied to the lumbar region:

    1. Future points on spinous projections from L1 to L5
    2. Lumbar region 2 from the middle point of the spinous output bilateral and 2 cm to 4 cm lateral points
    3. To each point of the iliac lobe of iliac crest will be injected subcutaneously with 0.5 ml 0.5% lidocaine-containing local anesthetic.
    4. 6 mm 30 gauge needle tip will be used for injection.
    5. For each patient who underwent subcutaneous local anesthetic, an average of 18-20 ml of 0.5% lidocaine-containing local anesthetic and 18-20 ml of 0.09% NaCl-containing isotonic saline will be used for each patient.

    6. These points are the points of quadle technique applied in neural therapy.

       • Kinesio taping will use 2 cut-to-length I-bands with a length of about 15 cm long for one patient. Space correction technique will be used for patients. The lumbar region of the patients will be glued vertically to the paravertebral muscles vertically 3-4 cm lateral to the spinous projections. As a starting point for patients, S1 will be adhered to the vertebra without tension, then the patient will be asked to come with maximum lumbar flexion posterior.

         • For a patient in the treatment of sham kinesio taping, 2 pieces of approximately 15 cm long ends will be used to cut the curved I bands. The lumbar region of the patients will be glued vertically to the paravertebral muscles vertically 3-4 cm lateral to the spinous projections. Patients in the upright posture, kinesio tape S1 applied from the vertebra without stretching will be glued upwards and taped upwards.

• Study Type: Interventional
• Enrollment (Actual): 84
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Eyalet/Yerleşke
    • Istanbul, Eyalet/Yerleşke, Turkey, 34000
      • Sultan 2.Abdülhamid Han Training and Research Hospital
    • Istanbul, Eyalet/Yerleşke, Turkey, 34000
      • Sultan Abdulhamid Han Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Under 18 years of age under 75 years
2. Chronic mechanic (decreased with resting and resting) for at least 3 months
3. Visual Analogue Scale score of at least 60-

Exclusion Criteria:

1. Having mental problems
2. Having the disease affecting the peripheral and central nervous system
3. Have received physical therapy in the lumbar region within the last 3 months
4. Injection into the lumbar region within the last 3 months
5. Having a history of waist region surgery
6. Low motor dysfunction in lower extremity in physical examination
7. Needle phobia
8. Is allergic to lidocaine
9. Kinesio tape allergy
10. Wound, infection, burn, allergic lesions in the application area

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: kinesio taping; two 15 cm I type kinesio tape applied longitudinally	Other: kinesio tape; two 15 cm I type kinesio tape applied longitudinally
Placebo Comparator: sham kinesio taping; two 15 cm I type kinesio tape applied longitudinally but without stretching	Other: kinesio tape; two 15 cm I type kinesio tape applied longitudinally
Experimental: local anesthetic; 18-20 cc %0.5 lidocaine subcutaneous injection	Other: local anesthetic; local anesthetic: 18-20 cc %0.5 lidocaine subcutaneous injection
Placebo Comparator: local serum physiologic; 18-20 cc % 0.09 NaCl subcutaneous injection	Other: local serum physiologic; serum physiologic : 18-20 cc % 0.09 NaCl subcutaneous injection

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain Severity: Visual Analog Scale	visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain	day 0 (before intervention)
Pain Severity: Visual Analog Scale	visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain	day 16 (after 6th application)
Pain Severity: Visual Analog Scale	visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain	1 month after intervention
Pain Severity: Visual Analog Scale	visual analog scale: minimum score: 0 maximum score: 10. Higher scores reflect more severe pain	3 months after intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Disability Severity: Oswestry Disabiliy Index	Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability	day 0 (before intervention)
Disability Severity: Oswestry Disability Index	Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability	day 16 (after 6th application)
Disability Severity: Oswestry Disability Index	Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability	1 month after intervention
Disability Severity: Oswestry Disability Index	Oswestry Disabiliy Index: minimum score: 0 maximum score: 50. Higher scores reflect more severe disability	3 months after intervention
Patient Reported Quality of Life: Short Form 36 Physical Functioning	short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life	day 0 (before intervention)
Patient Reported Quality of Life: Short Form 36 Physical Functioning	short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life	day 16 (after 6th application)
Patient Reported Quality of Life: Short Form 36 Physical Functioning	short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life	1 month after intervention
Patient Reported Quality of Life: Short Form 36 Physical Functioning	short form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. short form 36 physical functioning subscale scores are given. minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life	3 months after intervention
Spinal Mobility: Schober Test	Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.	day 0 (before intervention)
Spinal Mobility: Schober Test	Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.	day 16 (after 6th application)
Spinal Mobility: Schober Test	Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.	1 month after intervention
Spinal Mobility: Schober Test	Schober's test is classically used to determine if there is a decrease in lumbar spine range of motion (flexion). Patient is standing, examiner marks the L5 spinous process by drawing a horizontal line across the patients back. A second line is marked 10 cm above the first line. Patient is then instructed to flex forward as if attempting to touch his/her toes, examiner remeasures distance between two lines with patient fully flexed. The difference between the measurements in erect and flexion positions indicates the outcome of the lumbar flexion. Less than 5cm increase in length with forward flexion: Decreased lumbar spine range of motion.	3 months after intervention
Patient Reported Quality of Life: Short Form-36 Mental Health	Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.	day 0 before intervention
Patient Reported Quality of Life: Short Form-36 Mental Health	Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.	day 16 (after 6th application)
Patient Reported Quality of Life: Short Form-36 Mental Health	Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.	1 month after intervention
Patient Reported Quality of Life: Short Form-36 Mental Health	Short Form 36: The SF-36 form generates eight subscales. The eight subscales are: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Short Form-36 Mental health subscale scores are given. Mental minimum score: 0 maximum score: 100. Higher scores indicate a better of quality of life.	3 months after intervention

Collaborators and Investigators

• Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
• Investigators: Study Director: ADEM ERBİROL, Sultan Abdulhamid Han

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2019
• Primary Completion (Actual): June 1, 2019
• Study Completion (Actual): August 1, 2019

Study Registration Dates

• First Submitted: March 28, 2019
• First Submitted That Met QC Criteria: March 28, 2019
• First Posted (Actual): March 29, 2019

Study Record Updates

• Last Update Posted (Actual): April 13, 2021
• Last Update Submitted That Met QC Criteria: March 20, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: chronic low back pain; kinesio taping; local anesthetic; injection
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain; Physiological Effects of Drugs; Central Nervous System Depressants; Peripheral Nervous System Agents; Sensory System Agents; Anesthetics; Anesthetics, Local
• Other Study ID Numbers: ademerbirol

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: other researchers would get information from the main researcher. therefore it was not shared.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No